Researchers at Schulich School of Medicine & Dentistry are actively studying HIV to develop treatments and better understand the virus. The goal is to end HIV and AIDS as public health concerns by 2030, with targets set by UNAIDS. HIV is challenging to cure because it integrates into human DNA, making it difficult for the immune system to detect. Antiretroviral therapies are currently the main treatment for HIV, with recent advancements like Lenacapavir showing promise for prevention. Achieving the 95-95-95 targets requires investments in testing, treatment, education, and addressing social and economic barriers to care. The ultimate goal is to end the HIV epidemic through continued research and education.
Source link